Drawing for MEDABLE TELECONSENT

USPTO serial 97481256

MEDABLE TELECONSENT

Reviewed by CopyMark Law Group

Status 733Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
BROWNING, LUKE CASH
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 733: Status 733 means the fourth six-month extension was granted. Only one extension typically remains before you must file a Statement of Use or risk abandonment.

Need help with MEDABLE TELECONSENT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*

Plus Government fees of $250

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Omar M. Wadhwa

Omar M. Wadhwa CESARI AND MCKENNA, LLPONE LIBERTY SQUAREBOSTON, MA 02109United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software for operating and managing clinical trials by third parties; downloadable software for providing telemedicine services; downloadable software for providing medical and scientific research information in the field of pharmaceuticals and clinical trialsACTIVE—
042Software as a service (SaaS) services featuring software for operating and managing clinical trials by third parties; software as a service (SaaS) services featuring software for providing telemedicine services; software as a service (SaaS) services featuring software for providing medical and scientific research information in the field of pharmaceuticals and clinical trials; computer software platform as a service (PaaS) featuring computer software platforms for operating and managing clinical trials by third parties; computer software platform as a service (PaaS) featuring computer software platforms for providing telemedicine services; computer software platform as a service (PaaS) featuring computer software platforms for providing medical and scientific research information in the field of pharmaceuticals and clinical trialsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 8, 2025EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Jul 23, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 4, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 23, 2025EX4GSOU EXTENSION 4 GRANTED—
Jan 23, 2025EXT4SOU EXTENSION 4 FILED—
Jan 23, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 24, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 24, 2024EX3GSOU EXTENSION 3 GRANTED—
Jul 24, 2024EXT3SOU EXTENSION 3 FILED—
Jul 24, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 26, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 24, 2024EX2GSOU EXTENSION 2 GRANTED—
Jan 24, 2024EXT2SOU EXTENSION 2 FILED—
Jan 24, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 26, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 24, 2023EX1GSOU EXTENSION 1 GRANTED—
Jul 24, 2023EXT1SOU EXTENSION 1 FILED—
Jul 24, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 24, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 29, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 29, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 9, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 26, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 26, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Oct 26, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 26, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 26, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 26, 2022DOCKASSIGNED TO EXAMINER—
Jul 19, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 2, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance